Developer docs
API playgroundTry for free, no card

Search company profiles

Viveo

Full company profile

uuid0000szd

Namestring
Viveo
Legal namestring
CM Hospitalar S.A.
Websiteurl
viveo.com.br
Company typeenum
Public
Founded yearint
1996
Descriptiontext

Viveo is a vertically integrated Brazilian healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, sterile compounds, and consumer health products. Operating under legal entity CM Hospitalar S.A. and publicly listed on B3 (ticker VVEO3), the company runs 40+ operational units nationwide including 26+ distribution centers, 7 manufacturing factories, 12 sterile compounding pharmacies, and a proprietary fleet of 263 vehicles covering 900,000+ km/month. The ecosystem reaches 80% of Brazilian private hospitals within 24 hours and delivers to 10,000+ hospital/clinic units, 80,000 pharmacies, and 70,000 supermarkets. Major operating brands include Mafra (hospital/clinic distribution), Tecnocold (vaccines), Prevena (diagnostics), Cremer (first aid and consumer health), Neve (medical textiles), Healthlog (logistics), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), and Insuma (sterile compounding). The company employs 6,500-7,000 people and holds dominant positions in Brazilian wet wipes (50% market share including white-label) and private vaccine distribution (50%+ market share).

Short descriptiontext

Viveo is a Brazilian vertically integrated healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, and consumer health products across Brazil through 40+ operational units serving 10,000+ hospitals, 80,000 pharmacies, and 70,000 supermarkets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersRibeirão, Brazil
HQ citystring
Ribeirão
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare distribution, pharmaceutical logistics, medical supplies manufacturing, vaccine distribution, hospital materials supply
Industry2 codes
1Personal Care Wipes & On-the-Go Hygiene (Non-medical)
CodeCRADANAJPrimaryYes
2Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support)
CodeHLAGALAKPrimaryNo
NAICS code4 codes
  • Soap and Cleaning Compound Manufacturing32561
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Soap and Other Detergent Manufacturing325611
SIC code4 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics2840
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
Product category
Healthcare Distribution and Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model9 records
1Manufacturing & Product Sales
TypeOne Time License
Description

Viveo manufactures healthcare products including first-aid supplies, bandages, wet wipes, cotton products, surgical materials, hospital textiles, and private-label consumer goods. Revenue is generated through one-time product sales to pharmacies, supermarkets, hospitals, and industries. The company operates 7 factories across Brazil producing over 11 million packets of wet wipes per month and is the largest wet wipes manufacturer in Latin America.

viveo.com.br
2Distribution of Medical Products & Medications
TypeTransaction Fee
Description

Distribution of medications, medical materials, hospital supplies, and specialty nutrition through a national network of distribution centers. The company operates 26+ distribution centers and uses its own fleet of 263 vehicles, covering all five Brazilian regions and delivering to 80% of private hospitals within 24 hours. Revenue from distribution fees embedded in product pricing.

viveo.com.br
3Medication Subscription (Far.me)
TypeSubscription Recurring
Description

Direct-to-consumer medication subscription service acquired through the 100% acquisition of Far.me (Belo Horizonte-based healthtech). The subscription model delivers medications regularly to end consumers, generating recurring subscription revenue.

exame.com
4Diagnostic Distribution & Services (Prevena)
TypeTransaction Fee
Description

Prevena acts as a one-stop-shop diagnostic platform distributing pre-analytical products, reagents, lab equipment (Roche cobas, Sysmex urinanalysis), and providing technical support and logistics to clinical laboratories. Revenue from product distribution with integrated service support.

viveo.com.br
5Vaccine Distribution (Tecnocold)
TypeTransaction Fee
Description

Tecnocold distributes vaccines to approximately 100% of private clinics in Brazil and over 50% of the private vaccine market. Revenue from vaccine distribution and cold-chain logistics services, with presence at major industry events (ABCVAC).

viveo.com.br
6Logistics & Supply Chain Services (Healthlog)
TypeManaged Services
Description

Healthlog provides integrated logistics services including transport, inventory management, and storage for healthcare products. With its own fleet covering over 900,000 km/month, revenue is generated through logistics service fees.

viveo.com.br
7Patient Support Programs (Humania)
TypeProfessional Services
Description

Humania operates Patient Support Programs (PSP) providing adherence programs, treatment monitoring, and strategic solutions for pharmaceutical companies, health insurers, and private companies. Revenue from service contracts.

viveo.com.br
8Sterile Compounding Pharmacies (Insuma)
TypeTransaction Fee
Description

Insuma operates sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers across Brazil, positioned as the largest sterile compounding network in Latin America. Revenue from compounded pharmaceutical preparations.

viveo.com.br
9Private Label Manufacturing
TypeTransaction Fee
Description

Viveo's Private Label division manufactures products under retailer and brand owner labels, including wet wipes, hygiene products, and personal care items for major Brazilian retailers and multinational companies. Revenue from B2B manufacturing contracts.

viveo.com.br
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 14 records shown
1Mafra Saúde
Description

One stop shop for healthcare distribution

viveo.com.br
+13 more records
Core offering1 text field

Viveo is a Brazilian healthcare ecosystem that manufactures and distributes medical materials, medications, hospital supplies, vaccines, diagnostics, sterile injectables, and consumer healthcare products. The company operates 7 factories, 26+ distribution centers, and a fleet of 263 vehicles to serve hospitals, clinics, laboratories, pharmacies, and supermarkets across Brazil through a portfolio of specialized brands including Mafra, Cremer, Tecnocold, Prevena, Insuma, Neve, Healthlog, and Humania. The company also offers patient support programs and direct-to-consumer medication subscription via Far.me.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Viveo generates R$11.6 billion in annual revenue with R$706.3 million in adjusted EBITDA, demonstrating operational scale as Brazil's largest healthcare ecosystem
+5 more records
Product overview1 text field

Viveo is a Brazilian healthcare ecosystem comprising multiple business units that operate as an integrated platform. The company offers manufacturing, distribution, logistics, and digital services across the healthcare value chain. Key business units include Mafra (hospital/clinic distribution), Tecnocold (vaccine distribution serving 50%+ of private market), Prevena (diagnostic products distribution with Roche/Sysmex partnerships), Cremer (first aid/hygiene manufacturing and retail with brands Topz/Bellacotton/Salvelox/Piquitucho/FeelClean), Neve (medical textiles), Healthlog (logistics with 900,000+ km/month coverage), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), Insuma (sterile compounding pharmacy network - Latin America's largest), and a Private Label division (contract manufacturing with 8 factories producing wet wipes and personal care products). The ecosystem also operates Customer Care, a digital platform for order management with virtual assistant Mel. Viveo distributes to hospitals, clinics, laboratories, pharmacies, retailers, and end consumers across Brazil.

Product and service13 records
1Mafra
CategoryHealthcare Distribution
Description

One-stop-shop distribution company operating across multiple healthcare segments including medications, medical materials, hospital nutrition, and OPME (ortheses, prostheses, and medical devices). Serves hospitals and clinics through specialized verticals for high-complexity medications and surgical products.

2Tecnocold Vacinas
CategoryVaccine Distribution and Cold-Chain Logistics
Description

Market leader in vaccine distribution serving over 50% of Brazil's private vaccine market with presence in virtually 100% of private vaccine clinics. Operates the largest vaccine distribution center in Cajamar (SP) with the largest cold storage chamber in the market.

3Prevena Diagnóstica
CategoryDiagnostic Distribution and Laboratory Solutions
Description

Diagnostic distribution platform serving as a one-stop-shop delivering complete solutions from pre-analytical to analytical phases for clinical laboratories. Distributes products from Roche (cobas 8000 modular analyzer), Sysmex (urinanalysis), Neolab (collection tubes), and Autobio (hemoculture systems).

4Cremer
CategoryMedical Supplies Manufacturing and Consumer Healthcare
Description

Manufacturer and distributor of first aid, surgery, treatment, hygiene, and personal care products with over 88 years of experience. Serves both pharmacy and supermarket channels with owned brands including Piquitucho, Topz, Bellacotton, Salvelox, and FeelClean. Operates own wet wipes manufacturing.

5Neve Medical
CategoryMedical Textiles Manufacturing
Description

Manufacturer and distributor of medical textile products recognized for quality with RDC 16/2013 ANVISA Good Manufacturing Practices certification. Supplies hospital textiles, surgical materials, and medical clothing products to hospitals and clinics across Brazil.

6Healthlog
CategoryHealthcare Logistics and Supply Chain Services
Description

Integrated logistics services platform with proprietary fleet of 263 vehicles covering over 900,000 km/month and delivering throughout Brazil. Offers transport, inventory management, and storage services for healthcare products, with 8 fully electric trucks in Greater São Paulo.

7Humania
CategoryPatient Support Programs and Healthcare Services
Description

Patient Support Program (PSP) specialist offering humanized, innovative, and strategic solutions for pharmaceutical industry, health insurers, and private companies. Supports patient adherence programs, treatment monitoring, and specialty therapy management including oncology and infusion therapy.

8Mafra Especialidades
CategorySpecialty Pharmacy Distribution
Description

Specialty medications and materials distribution for retail and healthcare professionals with proximity service, speed, and complete assortment. Operates physical stores and online with Brazil-wide delivery of specialty pharmaceutical products.

9Insuma
CategorySterile Compounding Pharmacy
Description

National network of sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers. Portfolio includes enteral, parenteral, dialysis, and oncology solutions. Operates 12 sterile compounding pharmacies across Brazil.

10Private Label Division
CategoryContract Manufacturing and Private Label
Description

Contract manufacturing division offering high-technology products for national and international brands in Latin America. Operates 8 factories producing wet wipes, hygiene products, first aid items, and personal care solutions with over 11 million wet wipe packages per month capacity. Serves major Brazilian retailers and multinational brands.

11Far.me Medication Subscription
CategoryDirect-to-Consumer Medication Subscription
Description

Direct-to-consumer medication subscription service delivering medications regularly to end consumers. Subscription model launched since 2020 serving chronic medication patients with home delivery across Brazil.

12Boxifarma Automated Pharmaceutical Services
CategoryAutomated Pharmaceutical Services
Description

AI and robotics-driven personalized medication packaging technology that automates pharmaceutical dispensing and improves treatment management for patients. Uses Boxifarma's automated services to deliver customized multi-dose packaging through partner pharmacies.

13Customer Care Platform
CategoryDigital Customer Service Platform
Description

Digital customer service platform featuring Mel, a virtual assistant for simplified and secure order management. Offers features including duplicate invoices, fiscal documents, delivery receipts, technical complaints, and business policies access for B2B clients.

Scale indicator40 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-01
Description

Viveo and Papirus developed sustainable packaging for Cremer products using Vitacycle® paperboard with 40% post-consumer recycled content. The partnership includes the Papirus Circular Program for packaging traceability and recycling credits, involving Gráfica Edelmann (production) and Polen cleantech (carbon credit tracking). The project avoided 194 tonnes of CO2 equivalent emissions and processed 328+ tonnes of post-consumer material. The award-winning packaging covers Cremer, Bellacotton, and Topz brands.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Polen is a cleantech partner in the Papirus Circular Program tracking 100% of input invoices for post-consumer recycled material. Generates recycling credits for Viveo's sustainable packaging and provides a real-time impact tracking landing page (lps.brpolen.com.br/viveo).

Strategic tierCoreTypeTechnology or Integration
Description

Roche Diagnóstica partnered with Prevena (Viveo brand) to deploy the cobas® 8000 modular analyzer series in Brazilian clinical laboratories. The platform performs up to 9,800 tests/hour with 99%+ uptime. Prevena handles distribution, installation, technical support, and workflow optimization for Roche's high-throughput diagnostic platform across Brazil.

Strategic tierSupportingTypeTechnology or Integration
Description

Sysmex supplies urinanalysis technology distributed through Prevena, one of four major innovations launched by Prevena at CBAC 2025.

Strategic tierSupportingTypeTechnology or Integration
Description

Autobio hemoculture system is a new brand launched in Brazil through Prevena at CBAC 2025, expanding Prevena's diagnostic portfolio.

Strategic tierSupportingTypeTechnology or Integration
Description

Neolab collection tubes are an international brand being launched in Brazil through Prevena at CBAC 2025, expanding Prevena's pre-analytical portfolio.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Childhood Brasil partnered with Cremer (Viveo brand) to launch Curativos dos Direitos da Criança — bandages printed with phrases written by children to raise awareness about children's rights. Product available in pharmacies nationwide with QR Code linking to the organization's website. Created by Pullse agency.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Viveo holds a dermatology vertical contract for Allergan's botulinum toxin (Botox), which started generating increased sales and margin gains in Q3 2024. Viveo distributes Allergan's high-value dermocosmetics and botulinum products through its pharmaceutical distribution network.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Prevena participates in the CBAC congress organized by SBAC (50th edition in 2025), the largest clinical laboratory congress in Brazil, as an independent exhibitor for the first time since its 2022 launch.

10Associação Brasileira de Clínicas de Vacinas (ABCVAC)
Strategic tierSupportingTypeGTM or Marketing Partner
Description

Tecnocold participates in ABCVAC congress (June 2025 in São Paulo), leveraging the event to expand networking, understand market trends, and discuss relevant sector topics with private vaccine clinic professionals across Brazil.

viveo.com.br
11SESI
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Viveo partners with SESI for the 'Bem Nutrir' nutritional care program, sharing healthy eating information with professional nutritionists. SESI also partners on PCD (persons with disabilities) vocational training initiatives.

viveo.com.br
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Brazil's largest pharmaceutical company (HYPERA3), manufacturing branded generics, OTC, and consumer health products with strong distribution. Highly comparable to Viveo given its combination of pharma manufacturing, consumer health brands, and broad Brazilian distribution scale.

TypeDirect peer
Description

Brazilian pharmaceutical manufacturer with vertically integrated operations spanning branded generics, OTC, hospital, and prescription segments. Comparable to Viveo's Mafra and Cremer business units given its manufacturing-plus-distribution model serving both B2B and consumer channels.

TypeBroad incumbent
Description

US-based healthcare distribution and medical products company serving hospitals, pharmacies, and clinical laboratories globally. Comparable to Viveo's distribution business model across pharmaceuticals, medical-surgical products, and laboratory supplies at a broader geographic and category scale.

TypeBroad incumbent
Description

Global pharmaceutical distribution and healthcare services leader. Comparable to Viveo's Mafra and Healthlog distribution operations given the shared pharmaceutical distribution business model and end-to-end healthcare supply chain focus, though at vastly larger global scale.

TypeRegional player
Description

Brazil's largest pharmacy retail chain (RADL3) with 2,500+ stores. Comparable to Viveo as a downstream customer (80,000 pharmacies served by Cremer) and adjacent market participant in Brazilian consumer healthcare, though operating in retail rather than distribution/manufacturing.

TypeDirect peer
Description

Brazil's largest diagnostic medicine company (DASA3), operating clinical analysis labs and imaging centers nationwide. Directly comparable to Viveo's Prevena brand given overlap in clinical laboratory supply, diagnostic equipment distribution, and laboratory services to the same hospital/clinic customer base.

TypeRegional player
Description

Major Brazilian pharmacy retail chain (PGMN3) with extensive nationwide footprint. Comparable to Viveo as a downstream channel for Cremer consumer healthcare products and as an adjacent participant in the Brazilian consumer health retail market.

TypeDirect peer
Description

Largest Brazilian pharmaceutical company by units sold, with a broad portfolio across prescription, generics, OTC, and consumer health. Comparable to Viveo given its national distribution scale and diversified healthcare product portfolio reaching pharmacies and hospitals.

TypeDirect peer
Description

Major Brazilian diagnostic and clinical analysis company (FLRY3) operating labs and imaging centers. Comparable to Viveo's Prevena diagnostic distribution and laboratory services business given shared focus on serving the Brazilian clinical laboratory market with diagnostic products and services.

TypeDirect peer
Description

Brazilian consumer goods conglomerate spanning personal care, cosmetics, and household products. Comparable to Viveo/Cremer's branded consumer healthcare business (Topz, Bellacotton, Piquitucho, FeelClean) given shared focus on Brazilian CPG distribution through pharmacy and supermarket channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries21 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Viveo

Healthcare Distribution and Manufacturingviveo.com.br

Viveo is a Brazilian vertically integrated healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, and consumer health products across Brazil through 40+ operational units serving 10,000+ hospitals, 80,000 pharmacies, and 70,000 supermarkets.

What Viveo does

Viveo is a vertically integrated Brazilian healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, sterile compounds, and consumer health products. Operating under legal entity CM Hospitalar S.A. and publicly listed on B3 (ticker VVEO3), the company runs 40+ operational units nationwide including 26+ distribution centers, 7 manufacturing factories, 12 sterile compounding pharmacies, and a proprietary fleet of 263 vehicles covering 900,000+ km/month. The ecosystem reaches 80% of Brazilian private hospitals within 24 hours and delivers to 10,000+ hospital/clinic units, 80,000 pharmacies, and 70,000 supermarkets. Major operating brands include Mafra (hospital/clinic distribution), Tecnocold (vaccines), Prevena (diagnostics), Cremer (first aid and consumer health), Neve (medical textiles), Healthlog (logistics), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), and Insuma (sterile compounding). The company employs 6,500-7,000 people and holds dominant positions in Brazilian wet wipes (50% market share including white-label) and private vaccine distribution (50%+ market share).

Viveo firmographics

Firmographics
Name
Viveo
Legal name
CM Hospitalar S.A.
Website
https://viveo.com.br
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Viveo is a Brazilian vertically integrated healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, and consumer health products across Brazil through 40+ operational units serving 10,000+ hospitals, 80,000 pharmacies, and 70,000 supermarkets.
Ownership category
akta.pro rank

Viveo industry classification

Industry
Product category
Healthcare Distribution and Manufacturing
NAICS
Soap and Cleaning Compound Manufacturing (32561), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Soap and Other Detergent Manufacturing (325611)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Personal Care Wipes & On-the-Go Hygiene (Non-medical) (CRADANAJ)
akta.pro secondary industry
Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)

Keywords

  • Healthcare distribution
  • Pharmaceutical logistics
  • Medical supplies manufacturing
  • Vaccine distribution
  • Hospital materials supply

Where Viveo is headquartered

Location

Headquarters

HQ city
Ribeirão
HQ country
Brazil
HQ region
Latin America

Offices13 records

Markets served

Viveo business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Manufacturing & Product Sales: Viveo manufactures healthcare products including first-aid supplies, bandages, wet wipes, cotton products, surgical materials, hospital textiles, and private-label consumer goods. Revenue is generated through one-time product sales to pharmacies, supermarkets, hospitals, and industries. The company operates 7 factories across Brazil producing over 11 million packets of wet wipes per month and is the largest wet wipes manufacturer in Latin America.
  2. Distribution of Medical Products & Medications: Distribution of medications, medical materials, hospital supplies, and specialty nutrition through a national network of distribution centers. The company operates 26+ distribution centers and uses its own fleet of 263 vehicles, covering all five Brazilian regions and delivering to 80% of private hospitals within 24 hours. Revenue from distribution fees embedded in product pricing.
  3. Medication Subscription (Far.me): Direct-to-consumer medication subscription service acquired through the 100% acquisition of Far.me (Belo Horizonte-based healthtech). The subscription model delivers medications regularly to end consumers, generating recurring subscription revenue.
  4. Diagnostic Distribution & Services (Prevena): Prevena acts as a one-stop-shop diagnostic platform distributing pre-analytical products, reagents, lab equipment (Roche cobas, Sysmex urinanalysis), and providing technical support and logistics to clinical laboratories. Revenue from product distribution with integrated service support.
  5. Vaccine Distribution (Tecnocold): Tecnocold distributes vaccines to approximately 100% of private clinics in Brazil and over 50% of the private vaccine market. Revenue from vaccine distribution and cold-chain logistics services, with presence at major industry events (ABCVAC).
  6. Logistics & Supply Chain Services (Healthlog): Healthlog provides integrated logistics services including transport, inventory management, and storage for healthcare products. With its own fleet covering over 900,000 km/month, revenue is generated through logistics service fees.
  7. Patient Support Programs (Humania): Humania operates Patient Support Programs (PSP) providing adherence programs, treatment monitoring, and strategic solutions for pharmaceutical companies, health insurers, and private companies. Revenue from service contracts.
  8. Sterile Compounding Pharmacies (Insuma): Insuma operates sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers across Brazil, positioned as the largest sterile compounding network in Latin America. Revenue from compounded pharmaceutical preparations.
  9. Private Label Manufacturing: Viveo's Private Label division manufactures products under retailer and brand owner labels, including wet wipes, hygiene products, and personal care items for major Brazilian retailers and multinational companies. Revenue from B2B manufacturing contracts.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Viveo product offering

Product offering

Core offering

Viveo is a Brazilian healthcare ecosystem that manufactures and distributes medical materials, medications, hospital supplies, vaccines, diagnostics, sterile injectables, and consumer healthcare products. The company operates 7 factories, 26+ distribution centers, and a fleet of 263 vehicles to serve hospitals, clinics, laboratories, pharmacies, and supermarkets across Brazil through a portfolio of specialized brands including Mafra, Cremer, Tecnocold, Prevena, Insuma, Neve, Healthlog, and Humania. The company also offers patient support programs and direct-to-consumer medication subscription via Far.me.

Product overview

Viveo is a Brazilian healthcare ecosystem comprising multiple business units that operate as an integrated platform. The company offers manufacturing, distribution, logistics, and digital services across the healthcare value chain. Key business units include Mafra (hospital/clinic distribution), Tecnocold (vaccine distribution serving 50%+ of private market), Prevena (diagnostic products distribution with Roche/Sysmex partnerships), Cremer (first aid/hygiene manufacturing and retail with brands Topz/Bellacotton/Salvelox/Piquitucho/FeelClean), Neve (medical textiles), Healthlog (logistics with 900,000+ km/month coverage), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), Insuma (sterile compounding pharmacy network - Latin America's largest), and a Private Label division (contract manufacturing with 8 factories producing wet wipes and personal care products). The ecosystem also operates Customer Care, a digital platform for order management with virtual assistant Mel. Viveo distributes to hospitals, clinics, laboratories, pharmacies, retailers, and end consumers across Brazil.

Differentiator

Problem solved

Functional benefit

Brands

  • Mafra Saúde: One stop shop for healthcare distribution
  • Tecnocold Vacinas
  • Prevena
  • Cremer
  • Neve Medical
  • Health Log
  • Humania
  • Insuma
  • Embramed
  • Topz
  • Bellacotton
  • Salvelox
  • Piquitucho
  • FeelClean

Products and services

  • Mafra One-stop-shop distribution company operating across multiple healthcare segments including medications, medical materials, hospital nutrition, and OPME (ortheses, prostheses, and medical devices). Serves hospitals and clinics through specialized verticals for high-complexity medications and surgical products.
  • Tecnocold Vacinas Market leader in vaccine distribution serving over 50% of Brazil's private vaccine market with presence in virtually 100% of private vaccine clinics. Operates the largest vaccine distribution center in Cajamar (SP) with the largest cold storage chamber in the market.
  • Prevena Diagnóstica Diagnostic distribution platform serving as a one-stop-shop delivering complete solutions from pre-analytical to analytical phases for clinical laboratories. Distributes products from Roche (cobas 8000 modular analyzer), Sysmex (urinanalysis), Neolab (collection tubes), and Autobio (hemoculture systems).
  • Cremer Manufacturer and distributor of first aid, surgery, treatment, hygiene, and personal care products with over 88 years of experience. Serves both pharmacy and supermarket channels with owned brands including Piquitucho, Topz, Bellacotton, Salvelox, and FeelClean. Operates own wet wipes manufacturing.
  • Neve Medical Manufacturer and distributor of medical textile products recognized for quality with RDC 16/2013 ANVISA Good Manufacturing Practices certification. Supplies hospital textiles, surgical materials, and medical clothing products to hospitals and clinics across Brazil.
  • Healthlog Integrated logistics services platform with proprietary fleet of 263 vehicles covering over 900,000 km/month and delivering throughout Brazil. Offers transport, inventory management, and storage services for healthcare products, with 8 fully electric trucks in Greater São Paulo.
  • Humania Patient Support Program (PSP) specialist offering humanized, innovative, and strategic solutions for pharmaceutical industry, health insurers, and private companies. Supports patient adherence programs, treatment monitoring, and specialty therapy management including oncology and infusion therapy.
  • Mafra Especialidades Specialty medications and materials distribution for retail and healthcare professionals with proximity service, speed, and complete assortment. Operates physical stores and online with Brazil-wide delivery of specialty pharmaceutical products.
  • Insuma National network of sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers. Portfolio includes enteral, parenteral, dialysis, and oncology solutions. Operates 12 sterile compounding pharmacies across Brazil.
  • Private Label Division Contract manufacturing division offering high-technology products for national and international brands in Latin America. Operates 8 factories producing wet wipes, hygiene products, first aid items, and personal care solutions with over 11 million wet wipe packages per month capacity. Serves major Brazilian retailers and multinational brands.
  • Far.me Medication Subscription Direct-to-consumer medication subscription service delivering medications regularly to end consumers. Subscription model launched since 2020 serving chronic medication patients with home delivery across Brazil.
  • Boxifarma Automated Pharmaceutical Services AI and robotics-driven personalized medication packaging technology that automates pharmaceutical dispensing and improves treatment management for patients. Uses Boxifarma's automated services to deliver customized multi-dose packaging through partner pharmacies.
  • Customer Care Platform Digital customer service platform featuring Mel, a virtual assistant for simplified and secure order management. Offers features including duplicate invoices, fiscal documents, delivery receipts, technical complaints, and business policies access for B2B clients.

Quantifiable outcome

  • Viveo generates R$11.6 billion in annual revenue with R$706.3 million in adjusted EBITDA, demonstrating operational scale as Brazil's largest healthcare ecosystem
  • +5 more outcomes

Companies that use Viveo

Customer profile

Named customers7 records

Segments6 records

Ideal customer profiles6 records

Viveo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Viveo partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and supporting.

  • PapiruscoreStrategic or Co-development Partner · 1 August 2023Viveo and Papirus developed sustainable packaging for Cremer products using Vitacycle® paperboard with 40% post-consumer recycled content. The partnership includes the Papirus Circular Program for packaging traceability and recycling credits, involving Gráfica Edelmann (production) and Polen cleantech (carbon credit tracking). The project avoided 194 tonnes of CO2 equivalent emissions and processed 328+ tonnes of post-consumer material. The award-winning packaging covers Cremer, Bellacotton, and Topz brands.
  • PolensupportingStrategic or Co-development PartnerPolen is a cleantech partner in the Papirus Circular Program tracking 100% of input invoices for post-consumer recycled material. Generates recycling credits for Viveo's sustainable packaging and provides a real-time impact tracking landing page (lps.brpolen.com.br/viveo).
  • Roche DiagnósticacoreTechnology or IntegrationRoche Diagnóstica partnered with Prevena (Viveo brand) to deploy the cobas® 8000 modular analyzer series in Brazilian clinical laboratories. The platform performs up to 9,800 tests/hour with 99%+ uptime. Prevena handles distribution, installation, technical support, and workflow optimization for Roche's high-throughput diagnostic platform across Brazil.
  • SysmexsupportingTechnology or IntegrationSysmex supplies urinanalysis technology distributed through Prevena, one of four major innovations launched by Prevena at CBAC 2025.
  • AutobiosupportingTechnology or IntegrationAutobio hemoculture system is a new brand launched in Brazil through Prevena at CBAC 2025, expanding Prevena's diagnostic portfolio.
  • NeolabsupportingTechnology or IntegrationNeolab collection tubes are an international brand being launched in Brazil through Prevena at CBAC 2025, expanding Prevena's pre-analytical portfolio.
  • Childhood BrasilsupportingGTM or Marketing PartnerChildhood Brasil partnered with Cremer (Viveo brand) to launch Curativos dos Direitos da Criança — bandages printed with phrases written by children to raise awareness about children's rights. Product available in pharmacies nationwide with QR Code linking to the organization's website. Created by Pullse agency.
  • AllergansupportingChannel Partner/ Reseller/ DistributorViveo holds a dermatology vertical contract for Allergan's botulinum toxin (Botox), which started generating increased sales and margin gains in Q3 2024. Viveo distributes Allergan's high-value dermocosmetics and botulinum products through its pharmaceutical distribution network.
  • Sociedade Brasileira de Análises Clínicas (SBAC)supportingGTM or Marketing PartnerPrevena participates in the CBAC congress organized by SBAC (50th edition in 2025), the largest clinical laboratory congress in Brazil, as an independent exhibitor for the first time since its 2022 launch.
  • Associação Brasileira de Clínicas de Vacinas (ABCVAC)supportingGTM or Marketing PartnerTecnocold participates in ABCVAC congress (June 2025 in São Paulo), leveraging the event to expand networking, understand market trends, and discuss relevant sector topics with private vaccine clinic professionals across Brazil.
  • SESIsupportingStrategic or Co-development PartnerViveo partners with SESI for the 'Bem Nutrir' nutritional care program, sharing healthy eating information with professional nutritionists. SESI also partners on PCD (persons with disabilities) vocational training initiatives.

Scale indicators40 records

Recent moves7 records

Expansion highlights7 records

Viveo competitors and assessment

Company assessment

Direct peers

  • Hyper Pharma (Hypera S.A.): Brazil's largest pharmaceutical company (HYPERA3), manufacturing branded generics, OTC, and consumer health products with strong distribution. Highly comparable to Viveo given its combination of pharma manufacturing, consumer health brands, and broad Brazilian distribution scale.
  • Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with vertically integrated operations spanning branded generics, OTC, hospital, and prescription segments. Comparable to Viveo's Mafra and Cremer business units given its manufacturing-plus-distribution model serving both B2B and consumer channels.
  • Diagnósticos da América (Dasa): Brazil's largest diagnostic medicine company (DASA3), operating clinical analysis labs and imaging centers nationwide. Directly comparable to Viveo's Prevena brand given overlap in clinical laboratory supply, diagnostic equipment distribution, and laboratory services to the same hospital/clinic customer base.
  • EMS Pharma: Largest Brazilian pharmaceutical company by units sold, with a broad portfolio across prescription, generics, OTC, and consumer health. Comparable to Viveo given its national distribution scale and diversified healthcare product portfolio reaching pharmacies and hospitals.
  • Fleury: Major Brazilian diagnostic and clinical analysis company (FLRY3) operating labs and imaging centers. Comparable to Viveo's Prevena diagnostic distribution and laboratory services business given shared focus on serving the Brazilian clinical laboratory market with diagnostic products and services.
  • Grupo NC (formerly Hypermarcas): Brazilian consumer goods conglomerate spanning personal care, cosmetics, and household products. Comparable to Viveo/Cremer's branded consumer healthcare business (Topz, Bellacotton, Piquitucho, FeelClean) given shared focus on Brazilian CPG distribution through pharmacy and supermarket channels.

Broad incumbents

  • Cardinal Health: US-based healthcare distribution and medical products company serving hospitals, pharmacies, and clinical laboratories globally. Comparable to Viveo's distribution business model across pharmaceuticals, medical-surgical products, and laboratory supplies at a broader geographic and category scale.
  • McKesson Corporation: Global pharmaceutical distribution and healthcare services leader. Comparable to Viveo's Mafra and Healthlog distribution operations given the shared pharmaceutical distribution business model and end-to-end healthcare supply chain focus, though at vastly larger global scale.

Regional players

  • Raia Drogasil (RD Saúde): Brazil's largest pharmacy retail chain (RADL3) with 2,500+ stores. Comparable to Viveo as a downstream customer (80,000 pharmacies served by Cremer) and adjacent market participant in Brazilian consumer healthcare, though operating in retail rather than distribution/manufacturing.
  • Pague Menos: Major Brazilian pharmacy retail chain (PGMN3) with extensive nationwide footprint. Comparable to Viveo as a downstream channel for Cremer consumer healthcare products and as an adjacent participant in the Brazilian consumer health retail market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Viveo social profiles

Digital presence

Viveo compliance and trust

Trust signal

Compliance8 records

Viveo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Viveo leadership team

Management profile

Number of profiles

Profiles10 records

Viveo subsidiaries and ownership

Company hierarchy

Subsidiaries21 records

Viveo funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Viveo M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viveo

What does Viveo do?

Viveo is a Brazilian healthcare ecosystem that manufactures and distributes medical materials, medications, hospital supplies, vaccines, diagnostics, sterile injectables, and consumer healthcare products. The company operates 7 factories, 26+ distribution centers, and a fleet of 263 vehicles to serve hospitals, clinics, laboratories, pharmacies, and supermarkets across Brazil through a portfolio of specialized brands including Mafra, Cremer, Tecnocold, Prevena, Insuma, Neve, Healthlog, and Humania. The company also offers patient support programs and direct-to-consumer medication subscription via Far.me.

Is Viveo a public or private company?

Viveo is a public company. It is classified as public and is currently operating.

When was Viveo founded?

Viveo was founded in 1996. It employs 5,001 to 10,000 people.

Where is Viveo based?

Viveo is headquartered in Ribeirão, Brazil, in the Latin America region.

How does Viveo make money?

Nine revenue lines are on record. Manufacturing & Product Sales are the primary driver. The others are distribution of Medical Products & Medications, medication Subscription (Far.me), diagnostic Distribution & Services (Prevena), vaccine Distribution (Tecnocold), logistics & Supply Chain Services (Healthlog), patient Support Programs (Humania), sterile Compounding Pharmacies (Insuma) and private Label Manufacturing.

Who are Viveo's main competitors?

Direct peers on record are Hyper Pharma (Hypera S.A.), Eurofarma Laboratórios, Diagnósticos da América (Dasa), EMS Pharma, Fleury and Grupo NC (formerly Hypermarcas). Broad incumbents are Cardinal Health and McKesson Corporation. Regional players are Raia Drogasil (RD Saúde) and Pague Menos.

Does Viveo have an API?

No public API is recorded for Viveo.

What industry is Viveo in?

Viveo's product category is Healthcare Distribution and Manufacturing. Its primary akta.pro industry code is CRADANAJ, Personal Care Wipes & On-the-Go Hygiene (Non-medical), with a secondary code of HLAGALAK, Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support). Its NAICS code is 32561 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pegnIncêndio atinge fábrica da Cremer, controlada da Viveo, em BlumenauA fire struck a Cremer factory building in Blumenau, SC, around 5:30 a.m. on Monday, and was controlled by firefighters and the unit's emergency team. No injuries occurred, but production was halted and the company is assessing damage and potential impacts on supply.InfoMoneyPRIO, CSN, Méliuz, IRB, Viveo, Axia e mais ações para acompanhar hojeCorporate updates for the day include CSN's new president Fabio Schvartsman, PRIO's production drop of 5.2% to 186,100 boepd, and Viveo's capital increase of R$630.3 million. Méliuz saw JPMorgan cut stake to 4.95%, IRB kept A- ratings, and AXIA approved two R$1.5B debenture issuances.InfoMoneyHapvida, Desktop, Braskem, Viveo e mais ações para acompanhar hojeA corporate radar for Tuesday, 25, highlights Braskem's extrajudicial recovery plan, Viveo's B3 notice requiring its stock to be reclassified above R$ 1 by February 8, 2027, and Hapvida's response to a CVM question. Hapvida said it may adjust or discontinue collective contracts covering about 947,000 beneficiaries, while Squadra Gestão de Recursos cut its stake to roughly 3.87%.InfoMoneyViveo (VVOE3) recebe prazo da B3 para reenquadrar ações acima de R$ 1Viveo (VVEO3) said it received a notification from the B3 after its shares remained below R$ 1 since June 26, giving it until February 8, 2027 to reclassify the price. If the shares do not rise spontaneously, the company may propose a share grouping, with the board to review the proposal by January 15, 2027. The company is also advancing a capital increase of up to R$ 869.8 million via up to 966.4 million new shares at R$ 0.90 each.Investing.comEarnings call transcript: Viveo posts Q2 2026 miss as margins improve By Investing.comViveo reported a wider-than-expected second-quarter loss of -$0.24 per share and revenue below forecasts, marking the final stage of its six-quarter restructuring cycle. Despite the earnings miss, the Brazilian healthcare distributor achieved improved operational metrics, including expanded gross margins across all business lines, higher adjusted EBITDA, and increased free cash flow.Investing.comEarnings call transcript: Viveo posts Q2 2026 miss as margins improve By Investing.comViveo reported a wider-than-expected second-quarter loss and revenue below forecasts, missing both earnings and sales estimates for Q2 2026. Despite the miss, the Brazilian healthcare distributor highlighted significant operational improvements, including expanded gross margins across all business lines, a rise in adjusted EBITDA to its highest level since 2023, and a 36.6% increase in free cash flow.NeofeedNa Viveo, “o jogo é outro” depois de seis trimestres de ajustesViveo concluded its longest turnaround phase after six consecutive quarters of adjustments, reporting Q2 2026 net revenue of R$ 2.9 billion with adjusted EBITDA of R$ 216.7 million, representing 21.8% growth. The company's leverage ratio fell for the fifth consecutive quarter to 3.73x following debt renegotiation, with 93% of debt now on long-term terms. Viveo announced a capital increase of up to R$ 869.8 million that could reduce gross debt by more than 25%, potentially accelerating its deleveraging trajectory despite posting a net loss of R$ 21.3 million.AInvestViveo 2Q adj net loss R$21.3M, est. loss R$17.1MViveo Inc. reported a second-quarter adjusted net loss of R$21.3 million, surpassing the analyst estimate of R$17.1 million loss. The company's financial performance reflects ongoing challenges in managing profitability amid evolving market conditions and operational demands. The discrepancy between actual and estimated losses underscores the difficulty in forecasting financial outcomes in a dynamic business environment.Brazil JournalViveo anuncia mega aumento de capital; família Bueno converte dívidaViveo announced a capital increase of up to R$870 million, with 966.4 million shares at R$0.90 each, a 26.8% discount. DNA Capital, holding 37%, will subscribe the minimum R$427 million via debenture conversion. The move aims to reduce leverage from 3.88x to 2.7x if fully subscribed.Investing.comViveo Q4 2025 slides: record cash flow marks turnaround completion By Investing.comBrazilian healthcare solutions provider Viveo reported record fourth-quarter 2025 results on March 6, 2026, delivering consolidated net revenue of R$3,133 million (up 6.7% year-over-year) and full-year free cash flow of R$519.9 million—the strongest cash generation in company history. The turnaround, marked by margin expansion to 14.3% gross profit margin and leverage reduction to 3.97x net debt/EBITDA, culminated with a leadership transition as André Clark assumed the CEO role from Leonardo Byrro, while Viveo shares surged 10.66% to R$1.35 following the results release.